Learn about Novartis annual results, including media releases, annual reports, webcasts and presentations, and year-to-date figures.
Novartis' latest annual report shows a drop in sales of the drug in 2020. Colorado Biosciences Association Vice President Emily Roberts noted that the trade group does not believe Novartis' departure will undermine the industry's momentum in the state. She pointed to large operators such as ...
This statistic was assembled from several editions of Novartis' annual report. * With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015. ** During this year, eye care division Alcon was spun off and became an own company. Thus...
Explore the Novartis in Society Integrated Report. Investors Event calendar Financial data Novartis annual results Novartis quarterly results Novartis SEC filings Product sales Fixed-income securities Expected currency impact Share data an...
ESG rating performance Ratings by Access to Medicine Index, CDP, MSCI, Sustainalytics and ISS ESG. ESG targets We aim to improve equity in healthcare and to create sustainable social and environmental impact. Living wage We are committed to paying employees wages that cover basic living needs....
Novartis AG (NVS) - 6-K - Report of Foreign IssuerSEC FilingsFri, Jan. 31 Novartis AG (NVS) - IRANNOTICE - Notice of Iran-related disclosure filed pursuant to Section 13(r)(3) of the Exchange ActSEC FilingsFri, Jan. 31 Novartis AG (NVS) - 20-F - Annual and Transition Report (...
PTC's scientific approach and general development progress; and the factors discussed in the "Risk Factors" section of PTC's most recent Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time...
Real-Life Analysis of CML Management Demonstrates that Second-Line Therapy is Frequently Used But is Prematurely Discontinued For Intolerance: Report on Behalf of the CML-MPN Quebec Research Group. Poster presented at: EHA Annual Meeting; June 13, 2015. Hughes ...
Factors that may affect GSK’s operations include, but are not limited to, those described under Item 3.D “Principal risks and uncertainties” in GSK’s Annual Report on Form 20-F for 2017. Subject to the requirements of the Financial Conduct Authority (“FCA...
ESG rating performance Ratings by Access to Medicine Index, CDP, MSCI, Sustainalytics and ISS ESG. ESG targets We aim to improve equity in healthcare and to create sustainable social and environmental impact. Living wage We are committed to paying employees wages that cover basic living needs....